SlideShare a Scribd company logo
Skin Research Laboratory,
Technion , Institute of Technology
Haifa, Israel
Non–conventional T-Cells in Alopecia Areata
Amos Gilhar, M.D.
The pathogenesis of AA
Gilhar et al. Autoimmune Review 2016
Trichohyalin peptides
IL-13
Pre-existing
CD8+cells
Using the AA humanized SCID mouse model enabled us to find the role of various cells
and components such as:
• CD8+cells (effector cells) Gilhar A. et al. J Clin Invest 1998
• CD4+ cells (helper functions) Gilhar A. et al. Arch Dermatol 2002
• Melanocytes T cells Gilhar A. et al. J Invest Dermatol 2001
• Collapse of immune privilege Gilhar A. et al. J Invest Dermatol 2013
• Preventive effects of KV1.3 blocker Gilhar A, Etzioni A, Paus R. N Engl J Med. 2012
• and of PDE4 inhibitor Gilhar A, Schrum AG, Etzioni A, Waldmann H, Paus R. Autoimmun Rev. 2016
NKG2D+ cells Gilhar A. et al. . J Invest Dermatol 2013
NKG2D+ cells represent a rather mixed collection of
cells, such as:
CD8+
Type 1 innate lymphoid cells (ILC1)
NK cells
γδ-T cells
iNKT cells
Innate Lymphoid Cells
ILCs are important effector cells mediating Ag-independent immune responses and are
involved in various aspects.
Rankin L1, Groom J, Mielke LA, Seillet C, Belz GT. Diversity, function, and transcriptional regulation of
gut innate lymphocytes. Front Immunol. 2013;4:22.
& NKp44+
ILCs Classification
Induction of Psoriatic Skin by only ILC3+ cells
Normal Skin Graft
l
Psoriatic Induced Graft
Gilhar et al., Submitted
Humanized
Mouse
model
Human skin
Normal skin Psoriasis
Induction of Psoriatic Skin by ILC3+ cells
Gating
The presence of ILC1 cells in Alopecia Areata patient
(using immunofluorescence confocal microscopy)
NKp44/T-betNKp44/CD103 NKp44/CD103
ILC1+ cells in AA Patients
Normal
scalp skin
AA scalp skin
Classical NK cells in Human Alopecia Areata
NK triple staining (Perforin,CD161,CD117)
Distribution of ILC1 and ILC2 around the hair follicles
in AA patients
CD127
CRTH
Lineage -
CD127+
NKp44-
CRTH-
C-KIT -
CD161+
CRTH-
CD127+
Lineage -
NKp44 - C-KIT-NKp44 -
CD161+
ILC1
Isolation of ILC1 by FACS
Gaiting strategy of lin minus
Control
without
cells
150
cells
300
cells
300
cells
150
cells
300
cells
Per hair follicle
ILC1 ILC2 ILC3
Following six days in culture
Co-culture of normal hair follicles with ILCs
Control
without
cells
150
cells
300
cells
300
cells
150
cells
300
cells
Haircyclescore
Hair cycle score:
100 – Anagen
200 – Early catagen
300 – Mid catagen
400 – Late catagen ILC1 ILC2
ILC3
Hair Cycle Score Following Culture Of HFs With ILCs
Langan EA et al. Exp Dermatol 2015 24:903-11. doi: 10.1111/exd.1283
Very Preliminary Results
Indicate an Effect of ILC1 On
Human Hair Follicles
Pham et al. Front Immunol. 2016
Autoimmunity= Imbalance Between Regulatory and Effector Cell Activities
Protective cells
Effector T cells
Types of protective cells:
FOXP3 Regulatory T-cells
FOXP3 γδ T-cells
Regulatory NK-cells
FOXP3 iNKT-cells
iNKT10.
α - GalCer Expansion of NKT10 cells Repeated injections prevented the development of EAE
Sag J Clin Invest 124 :3725–3740, 2014
CD4/6B11
iNKT cells In
Alopecia
Areata Lesions
Hair Bulb
DP
Humanize AA Mouse Model
Gilhar et al. J Invest Dermatol 133:844-7,2013
Pre-incubation
PBMCs/IL-2/α-GalCer
Prevented the induction of AA
α-GalCer Induced Expansion of NKT10
PBMC’s/IL-2 PBMC’s/IL-2+ αGalCer
NKT10=
41.6%
NKT10=
1.3%
αGalCer
Without With
CD197-, CD3+, CD200+, CD49d+,
CD45RA+, CD279+, CD304+
The production levels of IL-10, IL-4, TGF-β and
IFN-γ cytokines by PBMCs were measured by ELISA
j
j
Regulatory role of iNKT/IL-10 in humanized AA mice
following treatment with α-GalCer
IL-10
IL-10
IL-10
IL-10
Double
staining
Double
staining
NKT
cells
Double
staining
NKT
cells
NKT
cells
NKT
cells
Double
staining
MeannumberofIL10+/NKT+cells
(per0.5mm2)
AA patient
Human alopecia
areata
AA likeNormal skin
Humanized
mouse model
AA like/GalCer
treatment
Healthy
volunteer
p=0.05
P<0.05
P<0.05
P<0.005
Mean number of IL-10/iNKT cells in lesional areas of AA patients
and
humanized mouse model
PBMC’s/IL-2
Depletion of
NKT cells(6B11)
Vα24
isotype control
(NKT cells (Vα24
blocking Abs
IL-10
isotype control
IL-10
blocking Abs
Meanhairnumber(pergraft) Number of Hair in Humanized AA mice
PBMC’s/IL -2 +α -Gal-Cer
Injection day
End of the study
IL-10 blocking Abs/ Ongoing AAIL-10 isotype Abs.
Pre-incubation/iNKT blocking Abs.NKT(Vα24) isotype control Abs.
CD8+ HLA-DR expression and in AA Induced Grafts/α-GalCer
HLA-DR-
HLA-DR+
HLA-DR+
HLA-DR+
HLA-DR+
HLA-DR+
DP
DP
Hair BulbHair Bulb
DP
DP
Hair Bulb
CD8+
iNKT Depletion
CD8+
DPCD8+
Hair Bulb
DP
CD8+
DP
CD8+
DP
Hair Bulb
α-GalCer & controls α-GalCer & blocking Abs.
α-GalCer & iNKT Depletion
Normal scalp skin before
induction of hair loss
Induction of AA
skinday 60))graft
Hair growth on AA induced graft /rIL-10 day
day105))treatment
Therapeutic Effect of IL-10 and α-Gal-Cer in AA mouse Model
Hair growth on AA induced graft /α-Gal-Cer
iNKT/IL10/CD1d in humanized AA mice following
treatment with α-GalCer
AA skin graft/α-GalCer AA skin graft
Correlation between increased number of NKT10
and normalization of scalp skin grafts
j
CONCLUSION
• α-Gal-Cer seems to possesses
therapeutic and preventive effects in
the humanized mouse model
Laboratory Staff
Aviad Keren , PhD
Nadia Smirnov , B A
Natalia Kaplun, M D
Gil Kaufman, PhD
Rimma Laufer, MD
Amal Ghraieb , MSc
Prof. R. Bergman
Rambam Medical
Center, Israel
Prof. Y. Ullmann
Rambam Medical
Center, Israel
Prof. A. Shemer
Sheba Medical
Center, Israel
Prof. Y. Refaeli,
University of Colorado, Denver
Prof. M. David
Beilinson Medical
Center, Israel
Prof. R. Paus
University of Manchester,UK
& Münster,Germany
Nira Goldstein, BA
Prof. A. Schrum, PhD
Mayo Clinic College,
Rochester, MN
Dr. A. Ginzburg
PBMC’s were incubated with IL-12, IL-18 and IL-33 for two
weeks (Silver JS et al.,2016).
Following incubation, ILC1 cells were isolated using FACS
sorter (Lineage - , CD127+, CRTH-, NKp44 -, c-KIT- and
CD161+ cells).
ILC2 cells (Lineage - , CD127+, CRTH+, c-KIT- and CD161+
cells).
ILC3 cells (Lineage - , CD127+, CRTH-, c-KIT+ and NKp44+
cells).
Autologous ILC1/ILC2/ILC3 cells were subsequently co-
cultured for six days with microdissected hair follicles
(150/300 cells per hair follicle).
Silver JS et al. Nat Immunol. 2016;17:626-35.
Protocol for Isolation of ILC1

More Related Content

What's hot

Chronic actinic dermatitis
Chronic actinic dermatitisChronic actinic dermatitis
Chronic actinic dermatitisChandan N
 
Lichenoid dermatoses.potx
Lichenoid dermatoses.potxLichenoid dermatoses.potx
Lichenoid dermatoses.potx
Ibrahim Farag
 
Hyper IgE syndrome
Hyper IgE syndromeHyper IgE syndrome
Xeroderma pigmentosum
Xeroderma pigmentosumXeroderma pigmentosum
Xeroderma pigmentosum
Alaa Osama
 
Xeroderma pigmentosum
Xeroderma pigmentosumXeroderma pigmentosum
Xeroderma pigmentosum
manasa kommineni
 
Epidermolysis bullosa complete
Epidermolysis bullosa  completeEpidermolysis bullosa  complete
Epidermolysis bullosa complete
Dr.vivek ranjan
 
Ichthyoses and Ichthyosiform disorders
Ichthyoses and Ichthyosiform disordersIchthyoses and Ichthyosiform disorders
Ichthyoses and Ichthyosiform disorders
Ibrahim Sharaf
 
Darier’s Disease
Darier’s DiseaseDarier’s Disease
Darier’s Disease
Ibrahim Farag
 
Eosiniphil in dermatology
Eosiniphil in dermatologyEosiniphil in dermatology
Eosiniphil in dermatology
chandraushavns
 
Primary immunodeficiencies
Primary immunodeficienciesPrimary immunodeficiencies
Primary immunodeficiencies
Sumudu Himesha Meawela
 
Desmosome & Desmoglein
Desmosome & DesmogleinDesmosome & Desmoglein
Desmosome & Desmoglein
Manoj Khadka
 
Gastroenterology
GastroenterologyGastroenterology
Gastroenterology
dr. Denny Rizaldi Arianto
 
Dermo epidermal junction
Dermo epidermal junctionDermo epidermal junction
Dermo epidermal junction
Shah Janak
 
Dermatological manifestation of systemic diseases
Dermatological manifestation of systemic diseasesDermatological manifestation of systemic diseases
Dermatological manifestation of systemic diseases
Shivshankar Badole
 
Previous year question on lichen planus based on neet pg, usmle, plab and fmg...
Previous year question on lichen planus based on neet pg, usmle, plab and fmg...Previous year question on lichen planus based on neet pg, usmle, plab and fmg...
Previous year question on lichen planus based on neet pg, usmle, plab and fmg...
Abhishek Gupta
 
Final version histologic intepretation of bxs for dermatitis
Final version histologic intepretation of bxs for dermatitisFinal version histologic intepretation of bxs for dermatitis
Final version histologic intepretation of bxs for dermatitisMarco Fusaro
 
Genodermatosis
GenodermatosisGenodermatosis
Genodermatosis
Mustafa Al Mously
 
Palmoplanter keratoderma
Palmoplanter keratoderma Palmoplanter keratoderma
Palmoplanter keratoderma
shery awan
 
Hypersensitivity Reactions
Hypersensitivity ReactionsHypersensitivity Reactions
Hypersensitivity Reactions
Joyshree Panda
 
Merkel cells
Merkel cellsMerkel cells
Merkel cells
ishita1994
 

What's hot (20)

Chronic actinic dermatitis
Chronic actinic dermatitisChronic actinic dermatitis
Chronic actinic dermatitis
 
Lichenoid dermatoses.potx
Lichenoid dermatoses.potxLichenoid dermatoses.potx
Lichenoid dermatoses.potx
 
Hyper IgE syndrome
Hyper IgE syndromeHyper IgE syndrome
Hyper IgE syndrome
 
Xeroderma pigmentosum
Xeroderma pigmentosumXeroderma pigmentosum
Xeroderma pigmentosum
 
Xeroderma pigmentosum
Xeroderma pigmentosumXeroderma pigmentosum
Xeroderma pigmentosum
 
Epidermolysis bullosa complete
Epidermolysis bullosa  completeEpidermolysis bullosa  complete
Epidermolysis bullosa complete
 
Ichthyoses and Ichthyosiform disorders
Ichthyoses and Ichthyosiform disordersIchthyoses and Ichthyosiform disorders
Ichthyoses and Ichthyosiform disorders
 
Darier’s Disease
Darier’s DiseaseDarier’s Disease
Darier’s Disease
 
Eosiniphil in dermatology
Eosiniphil in dermatologyEosiniphil in dermatology
Eosiniphil in dermatology
 
Primary immunodeficiencies
Primary immunodeficienciesPrimary immunodeficiencies
Primary immunodeficiencies
 
Desmosome & Desmoglein
Desmosome & DesmogleinDesmosome & Desmoglein
Desmosome & Desmoglein
 
Gastroenterology
GastroenterologyGastroenterology
Gastroenterology
 
Dermo epidermal junction
Dermo epidermal junctionDermo epidermal junction
Dermo epidermal junction
 
Dermatological manifestation of systemic diseases
Dermatological manifestation of systemic diseasesDermatological manifestation of systemic diseases
Dermatological manifestation of systemic diseases
 
Previous year question on lichen planus based on neet pg, usmle, plab and fmg...
Previous year question on lichen planus based on neet pg, usmle, plab and fmg...Previous year question on lichen planus based on neet pg, usmle, plab and fmg...
Previous year question on lichen planus based on neet pg, usmle, plab and fmg...
 
Final version histologic intepretation of bxs for dermatitis
Final version histologic intepretation of bxs for dermatitisFinal version histologic intepretation of bxs for dermatitis
Final version histologic intepretation of bxs for dermatitis
 
Genodermatosis
GenodermatosisGenodermatosis
Genodermatosis
 
Palmoplanter keratoderma
Palmoplanter keratoderma Palmoplanter keratoderma
Palmoplanter keratoderma
 
Hypersensitivity Reactions
Hypersensitivity ReactionsHypersensitivity Reactions
Hypersensitivity Reactions
 
Merkel cells
Merkel cellsMerkel cells
Merkel cells
 

Viewers also liked

Prevalence of Alopecia Areata Differs by Race in Two Large Cohorts
Prevalence of Alopecia Areata Differs by Race in Two Large CohortsPrevalence of Alopecia Areata Differs by Race in Two Large Cohorts
Prevalence of Alopecia Areata Differs by Race in Two Large Cohorts
National Alopecia Areata Foundation
 
Building an Ecosystem to Enable, Encourage and Support New Products for AA
Building an Ecosystem to Enable, Encourage and Support New Products for AABuilding an Ecosystem to Enable, Encourage and Support New Products for AA
Building an Ecosystem to Enable, Encourage and Support New Products for AA
National Alopecia Areata Foundation
 
Similarities between Type 1 Diabetes and Alopecia Areata
Similarities between Type 1 Diabetes and Alopecia AreataSimilarities between Type 1 Diabetes and Alopecia Areata
Similarities between Type 1 Diabetes and Alopecia Areata
National Alopecia Areata Foundation
 
A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular ...
A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular ...A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular ...
A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular ...
National Alopecia Areata Foundation
 
Xgain Presentation
Xgain PresentationXgain Presentation
Xgain Presentation
Kcresst Communication
 
Revisiting the Role of Immune Privilege in Alopecia Areata Pathobiology
Revisiting the Role of Immune Privilege in Alopecia Areata PathobiologyRevisiting the Role of Immune Privilege in Alopecia Areata Pathobiology
Revisiting the Role of Immune Privilege in Alopecia Areata Pathobiology
National Alopecia Areata Foundation
 
Repurposing Drugs for Alopecia Areata: The Vytorin Experience
Repurposing Drugs for Alopecia Areata: The Vytorin ExperienceRepurposing Drugs for Alopecia Areata: The Vytorin Experience
Repurposing Drugs for Alopecia Areata: The Vytorin Experience
National Alopecia Areata Foundation
 
Orphan Drug Designation
Orphan Drug DesignationOrphan Drug Designation
Orphan Drug Designation
National Alopecia Areata Foundation
 
Haircrowns
HaircrownsHaircrowns
Haircrowns
haircrowns
 
PCORI: Engaging Patients in Clinical Trials & Outcomes Research
PCORI: Engaging Patients in Clinical Trials & Outcomes ResearchPCORI: Engaging Patients in Clinical Trials & Outcomes Research
PCORI: Engaging Patients in Clinical Trials & Outcomes Research
National Alopecia Areata Foundation
 
Cytokine Targeted Therapeutics: Lessons from Atopic Dermatitis and Other Infl...
Cytokine Targeted Therapeutics: Lessons from Atopic Dermatitis and Other Infl...Cytokine Targeted Therapeutics: Lessons from Atopic Dermatitis and Other Infl...
Cytokine Targeted Therapeutics: Lessons from Atopic Dermatitis and Other Infl...
National Alopecia Areata Foundation
 
Nutcracker marketing
Nutcracker marketing Nutcracker marketing
Nutcracker marketing
Sukhada Dhone
 
Hair fall: Cause & Solution
Hair fall: Cause & SolutionHair fall: Cause & Solution
Hair fall: Cause & Solution
Dr Alok Tripathi
 
Understanding Parallels between Vitiligo and Alopecia Areata
Understanding Parallels between Vitiligo and Alopecia AreataUnderstanding Parallels between Vitiligo and Alopecia Areata
Understanding Parallels between Vitiligo and Alopecia Areata
National Alopecia Areata Foundation
 
Novel drug delivery systems
Novel drug delivery systemsNovel drug delivery systems
Novel drug delivery systems
Patel maulik
 
From Patient Focus Drug to Development to a Patient Reported Outcome: Develop...
From Patient Focus Drug to Development to a Patient Reported Outcome: Develop...From Patient Focus Drug to Development to a Patient Reported Outcome: Develop...
From Patient Focus Drug to Development to a Patient Reported Outcome: Develop...
National Alopecia Areata Foundation
 

Viewers also liked (18)

Prevalence of Alopecia Areata Differs by Race in Two Large Cohorts
Prevalence of Alopecia Areata Differs by Race in Two Large CohortsPrevalence of Alopecia Areata Differs by Race in Two Large Cohorts
Prevalence of Alopecia Areata Differs by Race in Two Large Cohorts
 
Building an Ecosystem to Enable, Encourage and Support New Products for AA
Building an Ecosystem to Enable, Encourage and Support New Products for AABuilding an Ecosystem to Enable, Encourage and Support New Products for AA
Building an Ecosystem to Enable, Encourage and Support New Products for AA
 
Similarities between Type 1 Diabetes and Alopecia Areata
Similarities between Type 1 Diabetes and Alopecia AreataSimilarities between Type 1 Diabetes and Alopecia Areata
Similarities between Type 1 Diabetes and Alopecia Areata
 
A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular ...
A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular ...A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular ...
A Sub-network of Signaling Protein Complexes in AA May Provide New Molecular ...
 
You Tube
You TubeYou Tube
You Tube
 
Xgain Presentation
Xgain PresentationXgain Presentation
Xgain Presentation
 
Revisiting the Role of Immune Privilege in Alopecia Areata Pathobiology
Revisiting the Role of Immune Privilege in Alopecia Areata PathobiologyRevisiting the Role of Immune Privilege in Alopecia Areata Pathobiology
Revisiting the Role of Immune Privilege in Alopecia Areata Pathobiology
 
Repurposing Drugs for Alopecia Areata: The Vytorin Experience
Repurposing Drugs for Alopecia Areata: The Vytorin ExperienceRepurposing Drugs for Alopecia Areata: The Vytorin Experience
Repurposing Drugs for Alopecia Areata: The Vytorin Experience
 
Orphan Drug Designation
Orphan Drug DesignationOrphan Drug Designation
Orphan Drug Designation
 
Haircrowns
HaircrownsHaircrowns
Haircrowns
 
PCORI: Engaging Patients in Clinical Trials & Outcomes Research
PCORI: Engaging Patients in Clinical Trials & Outcomes ResearchPCORI: Engaging Patients in Clinical Trials & Outcomes Research
PCORI: Engaging Patients in Clinical Trials & Outcomes Research
 
Cytokine Targeted Therapeutics: Lessons from Atopic Dermatitis and Other Infl...
Cytokine Targeted Therapeutics: Lessons from Atopic Dermatitis and Other Infl...Cytokine Targeted Therapeutics: Lessons from Atopic Dermatitis and Other Infl...
Cytokine Targeted Therapeutics: Lessons from Atopic Dermatitis and Other Infl...
 
Nutcracker marketing
Nutcracker marketing Nutcracker marketing
Nutcracker marketing
 
Hair fall: Cause & Solution
Hair fall: Cause & SolutionHair fall: Cause & Solution
Hair fall: Cause & Solution
 
Understanding Parallels between Vitiligo and Alopecia Areata
Understanding Parallels between Vitiligo and Alopecia AreataUnderstanding Parallels between Vitiligo and Alopecia Areata
Understanding Parallels between Vitiligo and Alopecia Areata
 
Alopecia
AlopeciaAlopecia
Alopecia
 
Novel drug delivery systems
Novel drug delivery systemsNovel drug delivery systems
Novel drug delivery systems
 
From Patient Focus Drug to Development to a Patient Reported Outcome: Develop...
From Patient Focus Drug to Development to a Patient Reported Outcome: Develop...From Patient Focus Drug to Development to a Patient Reported Outcome: Develop...
From Patient Focus Drug to Development to a Patient Reported Outcome: Develop...
 

More from National Alopecia Areata Foundation

What's New in Research: Genetics and Immunology of Alopecia Areata
What's New in Research: Genetics and Immunology of Alopecia AreataWhat's New in Research: Genetics and Immunology of Alopecia Areata
What's New in Research: Genetics and Immunology of Alopecia Areata
National Alopecia Areata Foundation
 
Pediatric Alopecia Areata: What's New in Management, Treatment and Education
Pediatric Alopecia Areata: What's New in Management, Treatment and EducationPediatric Alopecia Areata: What's New in Management, Treatment and Education
Pediatric Alopecia Areata: What's New in Management, Treatment and Education
National Alopecia Areata Foundation
 
Treatment of Alopecia Areata: Overview
Treatment of Alopecia Areata: OverviewTreatment of Alopecia Areata: Overview
Treatment of Alopecia Areata: Overview
National Alopecia Areata Foundation
 
NAAF Scientific Update
NAAF Scientific UpdateNAAF Scientific Update
NAAF Scientific Update
National Alopecia Areata Foundation
 
Translating advances in therapeutics to pediatrics
Translating advances in therapeutics to pediatricsTranslating advances in therapeutics to pediatrics
Translating advances in therapeutics to pediatrics
National Alopecia Areata Foundation
 
Therapeutic advances in alopecia areata
Therapeutic advances in alopecia areataTherapeutic advances in alopecia areata
Therapeutic advances in alopecia areata
National Alopecia Areata Foundation
 
The therapeutic landscape in atopic dermatitis
The therapeutic landscape in atopic dermatitisThe therapeutic landscape in atopic dermatitis
The therapeutic landscape in atopic dermatitis
National Alopecia Areata Foundation
 
Epidemiologic association between atopic dermatitis and alopecia areata
Epidemiologic association between atopic dermatitis and alopecia areataEpidemiologic association between atopic dermatitis and alopecia areata
Epidemiologic association between atopic dermatitis and alopecia areata
National Alopecia Areata Foundation
 
The evolving pathogenesis of alopecia areata and biomarkers of disease
The evolving pathogenesis of alopecia areata and biomarkers of diseaseThe evolving pathogenesis of alopecia areata and biomarkers of disease
The evolving pathogenesis of alopecia areata and biomarkers of disease
National Alopecia Areata Foundation
 
The atopic dermatitis pathogenesis and implications for alopecia areata
The atopic dermatitis pathogenesis and implications for alopecia areataThe atopic dermatitis pathogenesis and implications for alopecia areata
The atopic dermatitis pathogenesis and implications for alopecia areata
National Alopecia Areata Foundation
 
Genetics, Immunology and Therapeutic Targets Breakout Report
Genetics, Immunology and Therapeutic Targets Breakout ReportGenetics, Immunology and Therapeutic Targets Breakout Report
Genetics, Immunology and Therapeutic Targets Breakout Report
National Alopecia Areata Foundation
 
Health Economics and Burden of Disease Breakout Report
Health Economics and Burden of Disease Breakout ReportHealth Economics and Burden of Disease Breakout Report
Health Economics and Burden of Disease Breakout Report
National Alopecia Areata Foundation
 
Clinical Outcome Assessments Breakout Report
Clinical Outcome Assessments Breakout ReportClinical Outcome Assessments Breakout Report
Clinical Outcome Assessments Breakout Report
National Alopecia Areata Foundation
 
Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...
Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...
Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...
National Alopecia Areata Foundation
 
Broadening Diversity in Alopecia Areata Clinical Trial Participants
Broadening Diversity in Alopecia Areata Clinical Trial ParticipantsBroadening Diversity in Alopecia Areata Clinical Trial Participants
Broadening Diversity in Alopecia Areata Clinical Trial Participants
National Alopecia Areata Foundation
 
Willingness to Pay and Quality of Life in Alopecia Areata
Willingness to Pay and Quality of Life in Alopecia AreataWillingness to Pay and Quality of Life in Alopecia Areata
Willingness to Pay and Quality of Life in Alopecia Areata
National Alopecia Areata Foundation
 
Rare Genetic Mutations Contribute to Alopecia Areata Etiology
Rare Genetic Mutations Contribute to Alopecia Areata EtiologyRare Genetic Mutations Contribute to Alopecia Areata Etiology
Rare Genetic Mutations Contribute to Alopecia Areata Etiology
National Alopecia Areata Foundation
 
SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...
SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...
SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...
National Alopecia Areata Foundation
 
The Role of Patients in the Development of the Alopecia Areata Investigator G...
The Role of Patients in the Development of the Alopecia Areata Investigator G...The Role of Patients in the Development of the Alopecia Areata Investigator G...
The Role of Patients in the Development of the Alopecia Areata Investigator G...
National Alopecia Areata Foundation
 
2018 Alopecia Areata Research Summit: Summary of First Day
2018 Alopecia Areata Research Summit: Summary of First Day2018 Alopecia Areata Research Summit: Summary of First Day
2018 Alopecia Areata Research Summit: Summary of First Day
National Alopecia Areata Foundation
 

More from National Alopecia Areata Foundation (20)

What's New in Research: Genetics and Immunology of Alopecia Areata
What's New in Research: Genetics and Immunology of Alopecia AreataWhat's New in Research: Genetics and Immunology of Alopecia Areata
What's New in Research: Genetics and Immunology of Alopecia Areata
 
Pediatric Alopecia Areata: What's New in Management, Treatment and Education
Pediatric Alopecia Areata: What's New in Management, Treatment and EducationPediatric Alopecia Areata: What's New in Management, Treatment and Education
Pediatric Alopecia Areata: What's New in Management, Treatment and Education
 
Treatment of Alopecia Areata: Overview
Treatment of Alopecia Areata: OverviewTreatment of Alopecia Areata: Overview
Treatment of Alopecia Areata: Overview
 
NAAF Scientific Update
NAAF Scientific UpdateNAAF Scientific Update
NAAF Scientific Update
 
Translating advances in therapeutics to pediatrics
Translating advances in therapeutics to pediatricsTranslating advances in therapeutics to pediatrics
Translating advances in therapeutics to pediatrics
 
Therapeutic advances in alopecia areata
Therapeutic advances in alopecia areataTherapeutic advances in alopecia areata
Therapeutic advances in alopecia areata
 
The therapeutic landscape in atopic dermatitis
The therapeutic landscape in atopic dermatitisThe therapeutic landscape in atopic dermatitis
The therapeutic landscape in atopic dermatitis
 
Epidemiologic association between atopic dermatitis and alopecia areata
Epidemiologic association between atopic dermatitis and alopecia areataEpidemiologic association between atopic dermatitis and alopecia areata
Epidemiologic association between atopic dermatitis and alopecia areata
 
The evolving pathogenesis of alopecia areata and biomarkers of disease
The evolving pathogenesis of alopecia areata and biomarkers of diseaseThe evolving pathogenesis of alopecia areata and biomarkers of disease
The evolving pathogenesis of alopecia areata and biomarkers of disease
 
The atopic dermatitis pathogenesis and implications for alopecia areata
The atopic dermatitis pathogenesis and implications for alopecia areataThe atopic dermatitis pathogenesis and implications for alopecia areata
The atopic dermatitis pathogenesis and implications for alopecia areata
 
Genetics, Immunology and Therapeutic Targets Breakout Report
Genetics, Immunology and Therapeutic Targets Breakout ReportGenetics, Immunology and Therapeutic Targets Breakout Report
Genetics, Immunology and Therapeutic Targets Breakout Report
 
Health Economics and Burden of Disease Breakout Report
Health Economics and Burden of Disease Breakout ReportHealth Economics and Burden of Disease Breakout Report
Health Economics and Burden of Disease Breakout Report
 
Clinical Outcome Assessments Breakout Report
Clinical Outcome Assessments Breakout ReportClinical Outcome Assessments Breakout Report
Clinical Outcome Assessments Breakout Report
 
Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...
Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...
Alopecia Areata: Autoimmune Disease or Hair Follicle Response Pattern to Immu...
 
Broadening Diversity in Alopecia Areata Clinical Trial Participants
Broadening Diversity in Alopecia Areata Clinical Trial ParticipantsBroadening Diversity in Alopecia Areata Clinical Trial Participants
Broadening Diversity in Alopecia Areata Clinical Trial Participants
 
Willingness to Pay and Quality of Life in Alopecia Areata
Willingness to Pay and Quality of Life in Alopecia AreataWillingness to Pay and Quality of Life in Alopecia Areata
Willingness to Pay and Quality of Life in Alopecia Areata
 
Rare Genetic Mutations Contribute to Alopecia Areata Etiology
Rare Genetic Mutations Contribute to Alopecia Areata EtiologyRare Genetic Mutations Contribute to Alopecia Areata Etiology
Rare Genetic Mutations Contribute to Alopecia Areata Etiology
 
SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...
SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...
SSEA-Positive Myeloid Cells are Involved in Hair Loss in the Alopecia Areata ...
 
The Role of Patients in the Development of the Alopecia Areata Investigator G...
The Role of Patients in the Development of the Alopecia Areata Investigator G...The Role of Patients in the Development of the Alopecia Areata Investigator G...
The Role of Patients in the Development of the Alopecia Areata Investigator G...
 
2018 Alopecia Areata Research Summit: Summary of First Day
2018 Alopecia Areata Research Summit: Summary of First Day2018 Alopecia Areata Research Summit: Summary of First Day
2018 Alopecia Areata Research Summit: Summary of First Day
 

Recently uploaded

ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Temporomandibular Joint By RABIA INAM GANDAPORE.pptx
Temporomandibular Joint By RABIA INAM GANDAPORE.pptxTemporomandibular Joint By RABIA INAM GANDAPORE.pptx
Temporomandibular Joint By RABIA INAM GANDAPORE.pptx
Dr. Rabia Inam Gandapore
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
MGM SCHOOL/COLLEGE OF NURSING
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Dr Maria Tamanna
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 

Recently uploaded (20)

ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Temporomandibular Joint By RABIA INAM GANDAPORE.pptx
Temporomandibular Joint By RABIA INAM GANDAPORE.pptxTemporomandibular Joint By RABIA INAM GANDAPORE.pptx
Temporomandibular Joint By RABIA INAM GANDAPORE.pptx
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 

Non-Conventional T-cells in the Pathogenesis of Alopecia Areata

  • 1. Skin Research Laboratory, Technion , Institute of Technology Haifa, Israel Non–conventional T-Cells in Alopecia Areata Amos Gilhar, M.D.
  • 2. The pathogenesis of AA Gilhar et al. Autoimmune Review 2016 Trichohyalin peptides IL-13 Pre-existing CD8+cells
  • 3. Using the AA humanized SCID mouse model enabled us to find the role of various cells and components such as: • CD8+cells (effector cells) Gilhar A. et al. J Clin Invest 1998 • CD4+ cells (helper functions) Gilhar A. et al. Arch Dermatol 2002 • Melanocytes T cells Gilhar A. et al. J Invest Dermatol 2001 • Collapse of immune privilege Gilhar A. et al. J Invest Dermatol 2013 • Preventive effects of KV1.3 blocker Gilhar A, Etzioni A, Paus R. N Engl J Med. 2012 • and of PDE4 inhibitor Gilhar A, Schrum AG, Etzioni A, Waldmann H, Paus R. Autoimmun Rev. 2016 NKG2D+ cells Gilhar A. et al. . J Invest Dermatol 2013
  • 4. NKG2D+ cells represent a rather mixed collection of cells, such as: CD8+ Type 1 innate lymphoid cells (ILC1) NK cells γδ-T cells iNKT cells
  • 5. Innate Lymphoid Cells ILCs are important effector cells mediating Ag-independent immune responses and are involved in various aspects.
  • 6. Rankin L1, Groom J, Mielke LA, Seillet C, Belz GT. Diversity, function, and transcriptional regulation of gut innate lymphocytes. Front Immunol. 2013;4:22. & NKp44+ ILCs Classification
  • 7. Induction of Psoriatic Skin by only ILC3+ cells Normal Skin Graft l Psoriatic Induced Graft Gilhar et al., Submitted
  • 8. Humanized Mouse model Human skin Normal skin Psoriasis Induction of Psoriatic Skin by ILC3+ cells
  • 9. Gating The presence of ILC1 cells in Alopecia Areata patient (using immunofluorescence confocal microscopy)
  • 10. NKp44/T-betNKp44/CD103 NKp44/CD103 ILC1+ cells in AA Patients Normal scalp skin AA scalp skin
  • 11. Classical NK cells in Human Alopecia Areata NK triple staining (Perforin,CD161,CD117)
  • 12. Distribution of ILC1 and ILC2 around the hair follicles in AA patients
  • 13. CD127 CRTH Lineage - CD127+ NKp44- CRTH- C-KIT - CD161+ CRTH- CD127+ Lineage - NKp44 - C-KIT-NKp44 - CD161+ ILC1 Isolation of ILC1 by FACS Gaiting strategy of lin minus
  • 14. Control without cells 150 cells 300 cells 300 cells 150 cells 300 cells Per hair follicle ILC1 ILC2 ILC3 Following six days in culture Co-culture of normal hair follicles with ILCs
  • 15. Control without cells 150 cells 300 cells 300 cells 150 cells 300 cells Haircyclescore Hair cycle score: 100 – Anagen 200 – Early catagen 300 – Mid catagen 400 – Late catagen ILC1 ILC2 ILC3 Hair Cycle Score Following Culture Of HFs With ILCs Langan EA et al. Exp Dermatol 2015 24:903-11. doi: 10.1111/exd.1283
  • 16. Very Preliminary Results Indicate an Effect of ILC1 On Human Hair Follicles
  • 17. Pham et al. Front Immunol. 2016 Autoimmunity= Imbalance Between Regulatory and Effector Cell Activities Protective cells Effector T cells
  • 18. Types of protective cells: FOXP3 Regulatory T-cells FOXP3 γδ T-cells Regulatory NK-cells FOXP3 iNKT-cells iNKT10. α - GalCer Expansion of NKT10 cells Repeated injections prevented the development of EAE Sag J Clin Invest 124 :3725–3740, 2014
  • 20. Humanize AA Mouse Model Gilhar et al. J Invest Dermatol 133:844-7,2013 Pre-incubation PBMCs/IL-2/α-GalCer Prevented the induction of AA
  • 21. α-GalCer Induced Expansion of NKT10 PBMC’s/IL-2 PBMC’s/IL-2+ αGalCer NKT10= 41.6% NKT10= 1.3% αGalCer Without With CD197-, CD3+, CD200+, CD49d+, CD45RA+, CD279+, CD304+
  • 22. The production levels of IL-10, IL-4, TGF-β and IFN-γ cytokines by PBMCs were measured by ELISA j j
  • 23. Regulatory role of iNKT/IL-10 in humanized AA mice following treatment with α-GalCer IL-10 IL-10 IL-10 IL-10 Double staining Double staining NKT cells Double staining NKT cells NKT cells NKT cells Double staining
  • 24. MeannumberofIL10+/NKT+cells (per0.5mm2) AA patient Human alopecia areata AA likeNormal skin Humanized mouse model AA like/GalCer treatment Healthy volunteer p=0.05 P<0.05 P<0.05 P<0.005 Mean number of IL-10/iNKT cells in lesional areas of AA patients and humanized mouse model
  • 25. PBMC’s/IL-2 Depletion of NKT cells(6B11) Vα24 isotype control (NKT cells (Vα24 blocking Abs IL-10 isotype control IL-10 blocking Abs Meanhairnumber(pergraft) Number of Hair in Humanized AA mice PBMC’s/IL -2 +α -Gal-Cer Injection day End of the study
  • 26. IL-10 blocking Abs/ Ongoing AAIL-10 isotype Abs. Pre-incubation/iNKT blocking Abs.NKT(Vα24) isotype control Abs. CD8+ HLA-DR expression and in AA Induced Grafts/α-GalCer HLA-DR- HLA-DR+ HLA-DR+ HLA-DR+ HLA-DR+ HLA-DR+ DP DP Hair BulbHair Bulb DP DP Hair Bulb CD8+ iNKT Depletion CD8+ DPCD8+ Hair Bulb DP CD8+ DP CD8+ DP Hair Bulb α-GalCer & controls α-GalCer & blocking Abs. α-GalCer & iNKT Depletion
  • 27. Normal scalp skin before induction of hair loss Induction of AA skinday 60))graft Hair growth on AA induced graft /rIL-10 day day105))treatment Therapeutic Effect of IL-10 and α-Gal-Cer in AA mouse Model Hair growth on AA induced graft /α-Gal-Cer
  • 28. iNKT/IL10/CD1d in humanized AA mice following treatment with α-GalCer AA skin graft/α-GalCer AA skin graft
  • 29. Correlation between increased number of NKT10 and normalization of scalp skin grafts j
  • 30. CONCLUSION • α-Gal-Cer seems to possesses therapeutic and preventive effects in the humanized mouse model
  • 31. Laboratory Staff Aviad Keren , PhD Nadia Smirnov , B A Natalia Kaplun, M D Gil Kaufman, PhD Rimma Laufer, MD Amal Ghraieb , MSc Prof. R. Bergman Rambam Medical Center, Israel Prof. Y. Ullmann Rambam Medical Center, Israel Prof. A. Shemer Sheba Medical Center, Israel Prof. Y. Refaeli, University of Colorado, Denver Prof. M. David Beilinson Medical Center, Israel Prof. R. Paus University of Manchester,UK & Münster,Germany Nira Goldstein, BA Prof. A. Schrum, PhD Mayo Clinic College, Rochester, MN Dr. A. Ginzburg
  • 32. PBMC’s were incubated with IL-12, IL-18 and IL-33 for two weeks (Silver JS et al.,2016). Following incubation, ILC1 cells were isolated using FACS sorter (Lineage - , CD127+, CRTH-, NKp44 -, c-KIT- and CD161+ cells). ILC2 cells (Lineage - , CD127+, CRTH+, c-KIT- and CD161+ cells). ILC3 cells (Lineage - , CD127+, CRTH-, c-KIT+ and NKp44+ cells). Autologous ILC1/ILC2/ILC3 cells were subsequently co- cultured for six days with microdissected hair follicles (150/300 cells per hair follicle). Silver JS et al. Nat Immunol. 2016;17:626-35. Protocol for Isolation of ILC1